GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ensol Biosciences Inc (XKRX:140610) » Definitions » Pretax Margin %

Ensol Biosciences (XKRX:140610) Pretax Margin % : -1,236.12% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ensol Biosciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Ensol Biosciences's Pre-Tax Income for the six months ended in Dec. 2024 was ₩-17,734 Mil. Ensol Biosciences's Revenue for the six months ended in Dec. 2024 was ₩1,435 Mil. Therefore, Ensol Biosciences's pretax margin for the quarter that ended in Dec. 2024 was -1,236.12%.

The historical rank and industry rank for Ensol Biosciences's Pretax Margin % or its related term are showing as below:

XKRX:140610' s Pretax Margin % Range Over the Past 10 Years
Min: -6396.65   Med: -1478.9   Max: -577.49
Current: -1236.12


XKRX:140610's Pretax Margin % is ranked worse than
77.64% of 993 companies
in the Biotechnology industry
Industry Median: -122.46 vs XKRX:140610: -1236.12

Ensol Biosciences Pretax Margin % Historical Data

The historical data trend for Ensol Biosciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ensol Biosciences Pretax Margin % Chart

Ensol Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,721.67 -2,623.88 -577.49 -6,396.65 -1,236.12

Ensol Biosciences Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1,721.67 -2,623.88 -577.49 -6,396.65 -1,236.12

Competitive Comparison of Ensol Biosciences's Pretax Margin %

For the Biotechnology subindustry, Ensol Biosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ensol Biosciences's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ensol Biosciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Ensol Biosciences's Pretax Margin % falls into.


;
;

Ensol Biosciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Ensol Biosciences's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-17733.605/1434.621
=-1,236.12 %

Ensol Biosciences's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-17733.605/1434.621
=-1,236.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ensol Biosciences  (XKRX:140610) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Ensol Biosciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Ensol Biosciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ensol Biosciences Business Description

Traded in Other Exchanges
N/A
Address
51, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34036
Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is engaged in developing drugs for the diseases that have no therapeutic alternatives, such as a degenerative disc, osteoarthritis, cancer, Alzheimer's dementia, and type 1 diabetes. Its drugs portfolio includes Peniel 2000 Drug for Degenerative Disc Disease, Engedi 1000 Drug for Osteoarthritis, Charis 1000 Drug for Immuno-Oncology, Moriah 1000 Drug for Alzheimer's Disease, Shiloah 1000 Drug for Type I Diabetes, and EAD100 Drug for Animal Osteoarthritis.

Ensol Biosciences Headlines

No Headlines